Welcome to LookChem.com Sign In|Join Free

CAS

  • or

188813-02-7

Post Buying Request

188813-02-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

188813-02-7 Usage

Uses

3-Bromo-5-fluorobenzaldehyde is an intermediate in organic syntheses. Reatant in the synthesis of 3,4-diamino-3-cyclobutene-1,2-diones, 9,10-Dihydro-9,10-diboraanthracenes.

Check Digit Verification of cas no

The CAS Registry Mumber 188813-02-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,8,1 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 188813-02:
(8*1)+(7*8)+(6*8)+(5*8)+(4*1)+(3*3)+(2*0)+(1*2)=167
167 % 10 = 7
So 188813-02-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrFO/c8-6-1-5(4-10)2-7(9)3-6/h1-4H

188813-02-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H64042)  3-Bromo-5-fluorobenzaldehyde, 95%   

  • 188813-02-7

  • 5g

  • 588.0CNY

  • Detail
  • Alfa Aesar

  • (H64042)  3-Bromo-5-fluorobenzaldehyde, 95%   

  • 188813-02-7

  • 25g

  • 2352.0CNY

  • Detail
  • Alfa Aesar

  • (H64042)  3-Bromo-5-fluorobenzaldehyde, 95%   

  • 188813-02-7

  • 100g

  • 7242.0CNY

  • Detail

188813-02-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-BROMO-5-FLUOROBENZALDEHYDE

1.2 Other means of identification

Product number -
Other names 3-bromo-5-fluoro-benzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:188813-02-7 SDS

188813-02-7Relevant articles and documents

GLUCOSE SENSITIVE INSULIN DERIVATIVES

-

Page/Page column 115, (2020/10/20)

The present invention relates to novel insulin derivatives and their use in the treatment or prevention of medical conditions relating to diabetes. The insulin derivatives are glucose sensitive and display glucose-sensitive albumin binding. The invention

Method for synthesizing aromatic aldehyde through iron catalyzed oxidation allyl aromatic compound

-

Paragraph 0105-0107; 0151, (2019/06/27)

The invention discloses a method for synthesizing aromatic aldehyde through an iron catalyzed oxidation allyl aromatic compound. According to the specific method, under the promotion effect of hydrogen silane, with air or oxygen as the oxidant, the aromatic aldehyde compound is synthesized through the iron catalyzed oxidation allyl aromatic compound, the reaction temperature is 20-150 DEG C, and the time is 0.25-60 h. The method has the advantages that a catalyst source is wide, the price is low and the environment is protected; an oxidant source is wide, the price is low and no waste is generated; the reaction conditions are mild, selectivity is high and the yield is high; a substrate source is wide and stable; a substrate functional group is high in compatibility and a substrate is widein application range; complicated small molecules are compatible and can be well converted into aldehyde. The target product separation yield can reach up to 96% under the optimized reaction conditions.

Benzocarbazoles dioxane derivatives, its preparation process and its use in medicine

-

Paragraph 0738; 0740-0743, (2016/10/10)

The invention relates to a benzodioxane derivative, a preparation method thereof and application of the derivative in medicines. Specifically, the invention relates to a novel benzodioxane derivative shown as a formula (I), medial salt thereof or a medicine composition containing the derivative, and a preparation method of the derivative. The invention further relates to a use of the benzodioxane derivative and the medial salt thereof or the medicine composition containing the derivative in preparing therapeutic agent, especially GPR 40 agonist, and a drug for treating the diseases such as diabetes, metabolic disorders and the like, wherein each substituent group in the formula (I) is as defined in the description.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 188813-02-7